News

MOH Committed To Ensuring Safety Of Registered Vaccines

KUALA LUMPUR, Jan 18 — The Ministry of Health (MOH) is always committed to ensuring the quality, safety and effectiveness of vaccines and registered medicines are always guaranteed through the quality product monitoring program and also the pharmacovigilance.

Its Minister Datuk Seri Dr Adham Baba, in a statement today said the ministry would notify the public of the latest developments on the registered vaccines, from time to time.

“Those who experience adverse effects after receiving a vaccine can lodge reports to any healthcare facilities that administer vaccines or submit them to NPRA (the National Pharmaceutical Regulatory Division) through its website at https://npra.gov.my,” he said.

He was commenting on a report by the Norwegian Medicines Agency (NMA) on the death cases associated with the Pfizer-BioNTech vaccine in Norway.

Dr Adham said NPRA is seeking detailed information from Pfizer (M) Sdn Bhd as the product registration holder and closely monitoring the development of the issue, including actions taken by other international regulatory bodies such as the European Medicines Agency (EMA).

“Based on the initial report issued by the NMA, the deaths were among the elderly with illnesses and had history of chronic disease.

“Autopsies showed that the recipients (of the vaccine) had suffered fever, nausea and diarrhoea which are normal adverse effects after receiving immunisation and following that vaccination information updates are being carried out to take into account the recipient’s age and health condition,” he said.

Dr Adham said the COVID-19 vaccine produced by Pfizer-BioNTech, COMIRNATY Concentrate For Dispersion For Injection received conditional registration from the Drug Control Authority (PBKD) on Jan 8, this year.

“The efficacy and safety data for this vaccine was obtained from its third phase clinical trials conducted on 44,000 volunteers, including those aged above 75.

“The trials have shown a 95 per cent success rate of the vaccine in preventing symptomatic COVID-19 infection when it is given in two complete doses within 21 days. Clinical research shows that the adverse effects are tolerable and only temporary,” he added.

Sources: BERNAMA

Adib Mohd

Recent Posts

Zoom into Brilliance, HUAWEI Pura 80 Series Arrives in Malaysia with Unmatched Camera Power and Striking Design

HUAWEI Malaysia has officially unveiled its next-generation flagship lineup, the HUAWEI Pura 80 Series, setting a… Read More

18 hours ago

PayNet Joins MIT CSAIL’s FinTechAI Initiative as Sole Malaysian Member, Pioneering Ethical AI in Finance

Payments Network Malaysia Sdn Bhd (PayNet) has been named the sole Malaysian founding member of… Read More

18 hours ago

NakNak’s Bold Bulgogi Series: Big Flavours, Korean Vibes & A Side of Curly Fries

Homegrown quick service restaurant brand NakNak is turning up the flavour this season with the… Read More

1 day ago

Eco-Shop Ushers in Merdeka Spirit with Nationwide “Satu Senyuman, Seribu Makna” Campaign

Eco-Shop, Malaysia’s Leading Ultra Affordable Household Retailer, is calling on Malaysians to rediscover the beauty… Read More

2 days ago

Stephen Curry Takes Curry Camp Global, First Stop, Asia!

Stephen Curry is going global. For the first time ever, his iconic Curry Camp is… Read More

2 days ago

Charge Fast, Stay Cool, Live Free CUKTECH Celebrates Merdeka with Pocket-Sized Power Tools

Say hello to hassle-free charging, cool commutes, and gadgets that just work, anytime, anywhere. The… Read More

2 days ago

This website uses cookies.